Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    nursing professional development
    Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers
    January 22, 2021
    The Case of Concurrent Therapy Concerns
    Treatment side effects
    The Case of Concurrent Therapy Concerns
    December 18, 2020
    In a World Where You Can Be Anything, Be Kind
    Nurse staffing
    In a World Where You Can Be Anything, Be Kind
    December 11, 2020
    Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country
    Access to cancer care
    Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country
    December 04, 2020
    Why All Oncology Nurses Should Be Environmentalists
    Oncology nurse influence
    Why All Oncology Nurses Should Be Environmentalists
    November 27, 2020
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Research

    How Can Innovation and Opportunity Guide a Career in Nursing Research?
    Research

    How Can Innovation and Opportunity Guide a Career in Nursing Research?

    “Nursing is at the forefront of symptom management, and nurse-designed interventions lead the way,” Gwen Wyatt, RN, PhD, FAAN, FAPOS, recipient of the 2020 ONS Distinguished Nurse Researcher Award, said in a session at the inaugural ONS BridgeTM virtual conference in September 2020. She shared lessons from her career journey and told nurses that ONS can help them get their ideas “off the drawing board.”

    January 20, 2021
    Adding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer
    Chemotherapy

    Adding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer

    First-line therapy combining nivolumab with chemotherapy improved median overall survival rates in patients with PD-L1-expressing gastric cancer by 3.3 months in a large international, multicenter trial. The findings were reported during the 2020 European Society for Medical Oncology virtual meeting.

    December 30, 2020
    Genomics May Trick PARP Inhibitors to Treat More Cancers
    Research

    Genomics May Trick PARP Inhibitors to Treat More Cancers

    Turning on the body’s inflammasome with epigenetic therapy may improve the efficacy of PARP inhibitors across multiple tumor types, possibly expanding the therapy’s application to new cancers, researchers reported in Proceedings of the National Academy of Sciences.

    December 23, 2020
    Telegenetic Counseling Bridges Geographic Barriers and Minimizes Distress
    Research

    Telegenetic Counseling Bridges Geographic Barriers and Minimizes Distress

    Our 2009–2014 study, Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women, also known as the REACH Project (Risk Education and Assessment for Cancer Heredity), was the first randomized, noninferiority trial of telephone-based BRCA1 and BRCA2 counseling and testing that used a population-based traceback approach to identify and counsel both rural and urban women who were at increased risk for hereditary breast and ovarian cancer but had not received genetic counseling or testing.

    December 10, 2020
    NKT Cells May Be the Next Wave of CAR Therapy
    Research

    NKT Cells May Be the Next Wave of CAR Therapy

    When genetically modified with a chimeric antigen receptor (CAR), natural killer T (NKT) cells eliminated 50% of metastases in a patient with heavily pretreated, relapsed or refractory metastatic neuroblastoma, according to interim findings from an ongoing study that were published in Nature Medicine.

    December 02, 2020
    FDA Offers Guidance to Enhance Diversity in Clinical Trials
    Cultural/ethnic issues

    FDA Offers Guidance to Enhance Diversity in Clinical Trials

    The COVID-19 coronavirus continues to smother the United States, and nationwide efforts to flatten the curve aren’t lowering cases or preventing deaths. U.S. Food and Drug Administration (FDA) Commissioner Stephen M. Hahn, MD, an oncologist by training and profession, addressed the actions needed to combat COVID-19. One in particular is ensuring that clinical trials accurately reflect diverse populations.

    December 02, 2020
    NIH Turns 80, Shares FDR’s Timeless Message
    Health Policy

    NIH Turns 80, Shares FDR’s Timeless Message

    October 31, 2020, marked an important milestone in American public health: the 80th anniversary of President Franklin Delano Roosevelt’s dedication of the campus of the National Institutes of Health (NIH) in Bethesda, MD. 

    November 30, 2020
    Older Adults Are Being Overscreened for Cancer
    Cancer screening

    Older Adults Are Being Overscreened for Cancer

    Many older adults are continuing cancer screenings beyond the recommended upper age limits, which range from age 65–75 years depending on the type of cancer screening, researchers reported in JAMA Network Open.

    November 25, 2020
    Aspirin’s Cancer Benefits May Not Translate to Older Adults
    Research

    Aspirin’s Cancer Benefits May Not Translate to Older Adults

    Healthy older adults who take daily low-dose aspirin have increased risk of being diagnosed with advanced cancers and dying from cancer, according to findings from a new study published in the Journal of the National Cancer Institute.

    November 18, 2020
    Patients With Gynecologic Cancers Have Significant Fatigue After Surgery
    Cancer surgery

    Patients With Gynecologic Cancers Have Significant Fatigue After Surgery

    Forty-eight percent of women with gynecologic cancers report experiencing clinically significant fatigue after surgery that may continue six months (44%) and one (39%) year later, researchers reported in study findings published in Cancer.

    November 12, 2020
    Research Shows That Telehealth Has the Power to Meet the Needs of Vulnerable Communities
    Research

    Research Shows That Telehealth Has the Power to Meet the Needs of Vulnerable Communities

    Telehealth resources have been present in the United States for several decades. Traditionally, clinicians used telehealth to help rural populations with limited access to care. However, telehealth innovations expand beyond home care coordination. We can use technology to reach even the most remote and vulnerable patients.  

    November 11, 2020
    We Need More Evidence to Assess Technologies for Oral Adherence
    Oral adherence

    We Need More Evidence to Assess Technologies for Oral Adherence

    Oral anticancer agents are often expensive, and ensuring that patients have the financial means to pay for the medication is the first important step to improving adherence rates. Each health system has a group of individuals, not technology, to manage access to financial assistance. Even if they can afford the therapy, however, patients often struggle to maintain oral adherence.

    November 05, 2020
    Nursing Is Science First; It Just Appears Heroic
    ONS Leadership

    Nursing Is Science First; It Just Appears Heroic

    Science, our reliance on the foundations of epidemiology, and management of a public health crisis have been unprecedented discussion topics this year. We have never had a greater need to rely on data, science, and the evolving understanding of experts about the COVID-19 coronavirus and how to contend with it.

    November 02, 2020
    NCI Appoints New Director for Office of Cancer Survivorship
    Survivorship

    NCI Appoints New Director for Office of Cancer Survivorship

    Until recently, past ONS President Deborah Mayer, PhD, RN, AOCN®, FAAN, served as interim director of the National Cancer Institute’s (NCI’s) Office of Cancer Survivorship, a part of the Division of Cancer Control and Population Sciences. As an oncology nurse, Mayer brought a special perspective to the office’s mission to better understand and meet the unique needs of the growing number of U.S. cancer survivors.

    October 29, 2020
    New NINR Director Celebrates Health Equity and Diverse Nursing Roles
    Oncology nursing roles

    New NINR Director Celebrates Health Equity and Diverse Nursing Roles

    Patients throughout the United States still face persistent inequities across the healthcare continuum because of social determinants of health and inequity in research, Shannon N. Zenk, PhD, MPH, RN, FAAN, director of the National Institute of Nursing Research (NINR) recognized.

    October 26, 2020
    Study Links HPV Vaccine to Reduced Rates of Cervical Cancer
    Research

    Study Links HPV Vaccine to Reduced Rates of Cervical Cancer

    Cervical cancer rates have dropped more than 90% among women who received the human papillomavirus (HPV) vaccine, according to the results of a Swedish study published in the New England Journal of Medicine. Global health leaders are calling it a milestone study. 

    October 23, 2020
    FDA Approves Nivolumab and Ipilimumab for Malignant Pleural Mesothelioma
    U.S. Food and Drug Administration (FDA)

    FDA Approves Nivolumab and Ipilimumab for Malignant Pleural Mesothelioma

    On October 2, 2020, the U.S. Food and Drug Administration (FDA) approved nivolumab in combination with ipilimumab for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery. This is the first drug regimen approved for mesothelioma in 16 years and the second FDA-approved systemic therapy for mesothelioma. 

    October 05, 2020
    ACA Led to Higher Rates of Early Breast Cancer Diagnoses
    Research

    ACA Led to Higher Rates of Early Breast Cancer Diagnoses

    Thanks to expanded Medicaid coverage from the Affordable Care Act (ACA), women diagnosed with breast cancer—and in particular, African American women who are more likely to experience breast cancer disparities—are getting their cancers found at earlier stages, according to researchers. The study findings were reported in JAMA Surgery.

    August 19, 2020
    Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors
    Survivorship

    Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors

    Although opioid-related deaths are increasing in the general U.S. population, leading to the U.S. Department of Health and Human Services declaring it a public health emergency, new research shows that the increase is much smaller among patients with cancer, even though opioids are used as an option for cancer-related pain. The findings were published in JAMA Oncology.

    July 16, 2020
    NIH Study Links Cigarette Smoking to Higher Stroke Risk in African Americans
    Lung Cancer

    NIH Study Links Cigarette Smoking to Higher Stroke Risk in African Americans

    The disproportionate adverse health impact from smoking on African Americans is striking. Although oncology nurses are well aware of tobacco’s carcinogenic effects, they also need to understand the implications for comorbid conditions they may see in smokers with cancer. A recent study, through the National Institutes of Health (NIH), confirmed that African Americans have a 2.5 times higher incident of smoking-related strokes than those who never smoke.

    July 06, 2020
    Investigational Maintenance Therapy Extends Survival in AML
    Cancer treatments

    Investigational Maintenance Therapy Extends Survival in AML

    A new drug is extending both remission and survival in adults with acute myeloid leukemia (AML), according to findings reported at the American Society of Hematology annual meeting in December 2019. The study was funded by Celgene, the drug’s manufacturer.

    May 20, 2020
    Research Is Needed to Better Understand Combination Immunotherapy Side Effects
    Research

    Research Is Needed to Better Understand Combination Immunotherapy Side Effects

    Combination immunotherapy treatments are revolutionizing the way cancer care is delivered. As an ongoing evolution of care, nurses are administering different treatment modalities on a regular basis. Treatments include using multiple immunotherapy drugs in tandem, combining chemotherapy with immunotherapy, using targeted therapies with immunotherapy, and even involving radiation with immunotherapy. The move toward multiple-drug modalities will continue to change nursing practice, and nurses must have a basis of knowledge and evidence from which to work.

    May 12, 2020
    New NCI Initiative Boosts CAR T-Cell Therapy Research
    Research

    New NCI Initiative Boosts CAR T-Cell Therapy Research

    While the world is in the throes of the COVID-19 coronavirus pandemic, cancer research marshals forward with a focus on CAR T-cell therapy. 

    April 29, 2020
    NIH Announces Research Strategy for COVID-19
    Cancer research

    NIH Announces Research Strategy for COVID-19

    From international guidelines to economic stimulus and legislative support, the COVID-19 coronavirus pandemic is now global leaders’ top priority. Leading the research efforts is the National Institutes for Health’s (NIH) National Institute of Allergy and Infectious Disease (NIAID). As NIAID’s director for more than 30 years, Anthony Fauci, MD is one of the few, regular faces associated with COVID-19 in the United States. On April 23, 2020, the agency announced that it will spearhead a strategic plan to research a vaccine for COVID-19. 

    April 29, 2020
    The Evidence for Herbal Supplements for Immunity and Stress During COVID-19
    COVID-19

    The Evidence for Herbal Supplements for Immunity and Stress During COVID-19

    As the world embarks on unprecedented research efforts to prevent and treat the COVID-19 coronavirus, patients with cancer and healthcare providers alike may be interested in using herbal products to boost their immune system or relieve anxiety and stress. However, finding accurate information is challenging: no herbs have been scientifically proven to prevent or treat COVID-19, and some may even cause harm.

    April 29, 2020
    NCI Cancer Research Persists Despite COVID-19 Limitations 
    COVID-19

    NCI Cancer Research Persists Despite COVID-19 Limitations 

    Most of the global biomedical research community, especially those at the National Institutes of Health (NIH), is consumed with the COVID-19 coronavirus pandemic. Because the U.S. federal government is under strict orders to limit its operations to only essential personnel, many of the 27 NIH institutes and centers are redirecting their efforts toward COVID-19 topics. However, the National Cancer Institute (NCI) is continuing its cancer research in certain priority areas.   

    April 08, 2020
    What the Evidence Says About Acupuncture and Cognitive-Behavioral Therapy for Insomnia
    Complementary therapy

    What the Evidence Says About Acupuncture and Cognitive-Behavioral Therapy for Insomnia

    Sleep disturbances such as insomnia are prevalent and persistent among cancer survivors and diminish quality of life. Because of adverse effects such as continued sleep difficulty, memory disturbances, and falls associated with conventional medications, many patients prefer nonpharmaceutical options to address their insomnia.

    April 08, 2020
    Adding MRI to Prostate Cancer Testing Improves Accuracy, NIH Study Says
    Prostate cancer

    Adding MRI to Prostate Cancer Testing Improves Accuracy, NIH Study Says

    Combining a traditional 12-point biopsy with magnetic resonance imaging (MRI) improves the accuracy of prostate cancer diagnosis, according to findings from a new National Institutes of Health (NIH) study published in the New England Journal of Medicine. 

    March 26, 2020
    Radiation Unnecessary for Children With ALL
    Radiation therapy

    Radiation Unnecessary for Children With ALL

    Children with acute lymphoblastic leukemia (ALL) at risk for cancer recurrence in the brain don’t need prophylactic radiation therapy, researchers reported in the Journal of Clinical Oncology. 

    March 18, 2020
    U.S. Still Has Declining Cancer Death Rates, Latest National Report Says
    Research

    U.S. Still Has Declining Cancer Death Rates, Latest National Report Says

    Overall cancer death rates fell 1.5% on average per year from 2001–2017 in the United States for all cancer sites combined, according to the Annual Report to the Nation on the Status of Cancer from the Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), American Cancer Society, and North American Association of Central Cancer Registries.

    March 16, 2020
    NIDA Calls for Further Cannabis Research in Congress Testimony
    Health Policy

    NIDA Calls for Further Cannabis Research in Congress Testimony

    Medical cannabis has been approved for use in more than 33 states, many of which have decriminalized its use as well, and a health policy wave has spread across the country through state referendums to ease the burden for legalizing cannabis for health purposes. It’s a different world than it was 30 years ago, and the National Institute on Drug Abuse (NIDA) is frequently called to testify before Congress to address concerns and questions from lawmakers.

    March 12, 2020
    PCORI Reauthorization Funds Program Through 2029
    Health Policy

    PCORI Reauthorization Funds Program Through 2029

    Patient-centered research is vital in the effort to move the needle in cancer care, and nurse researchers rely on funding from organizations like the Patient-Centered Outcomes Research Institute (PCORI) to support new and ongoing studies. In December 2019, the U.S. House of Representatives approved the Further Consolidation Appropriations Act, 2020 (H.R. 1865), extending funding for PCORI through fiscal year 2029.

    March 11, 2020
    Oncolytic Virus Kills Tumor Cells While Supporting T Cells
    Research

    Oncolytic Virus Kills Tumor Cells While Supporting T Cells

    A new type of dual-function oncolytic virus that simultaneously kills cancer cells while increasing levels of leptin to support T cells is showing promise in melanoma mouse models, researchers reported in Immunity.   

    March 11, 2020
    Research Suggests New Nurses Could Help Address the Ambulatory Staffing Issue
    Research

    Research Suggests New Nurses Could Help Address the Ambulatory Staffing Issue

    As use of ambulatory care settings continues to grow, so too does the demand for expertly trained nurses to staff them. Unfortunately, nurse staffing levels have struggled to meet the burgeoning need in ambulatory clinics throughout the country. Traditionally, undergraduates receive limited ambulatory-specific education in nursing school, leaving them unprepared to enter those settings after graduation. However, the nursing shortage complicates staffing issues, and we must develop programs to direct new graduate nurses into ambulatory oncology careers.  

    March 10, 2020
    Smoking Rates Are Low, But Here’s How They Can Be Lower
    Lung Cancer

    Smoking Rates Are Low, But Here’s How They Can Be Lower

    Although U.S. smoking rates have hit an all-time low of 14%, 34 million American adults are still considered active smokers, according to the U.S. surgeon general’s January 2020 report on smoking cessation. It’s the first new report focused directly on smoking cessation from the surgeon general’s office in 30 years. 

    March 04, 2020
    Cancer Death Rates See Largest-Ever Single-Year Drop
    American Cancer Society (ACS)

    Cancer Death Rates See Largest-Ever Single-Year Drop

    Overall U.S. cancer mortality fell 2.2% from 2016 to 2017, the largest reduction for a single year, according to the American Cancer Society’s “Cancer Statistics, 2020,” published in CA: A Cancer Journal for Clinicians.

    February 26, 2020
    HPV Vaccine Has an Indirect Benefit: Herd Immunity
    Research

    HPV Vaccine Has an Indirect Benefit: Herd Immunity

    As more people receive the human papillomavirus (HPV) vaccine to protect themselves from strains of the virus that can cause cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers, researchers are starting to see herd immunity, where even people who haven’t received the vaccine are developing fewer oral HPV infections. The findings were published in JAMA.

    February 19, 2020
    Women With Diabetes Are Less Likely to Get Cancer Screenings
    Research

    Women With Diabetes Are Less Likely to Get Cancer Screenings

    Modest differences may exist among women with diabetes compared to healthy controls when it comes to adhering to screening recommendations for breast, cervical, and colorectal cancers, according to results of a study published in Diabetologia.

    February 12, 2020
    Nurses Are Central to Lung Cancer Screening Conversations
    Cancer screening

    Nurses Are Central to Lung Cancer Screening Conversations

    Participation in clinician and patient conversations about lung cancer screening—as well as the actual screening itself—is relatively low. According to one study, only 3.9% of screening-
    eligible patients had undergone lung cancer screening. Because the screening recommendations are newer, most patients are unaware that they exist, and research highlights that only 10%–12% of the patient population has had conversations with their clinicians about it.

    February 10, 2020
    Blood Test May Show Earliest Warning of Breast Cancer
    Research

    Blood Test May Show Earliest Warning of Breast Cancer

    Identifying a panel of tumor-associated antigens and autoantibodies through a simple blood test may one day help providers diagnose the earliest stages of breast cancer, before clinical signs appear.

    February 05, 2020
    Study Drug Plus Immunotherapy May Offer New Treatment Option for Lung and Kidney Cancer
    Treatments

    Study Drug Plus Immunotherapy May Offer New Treatment Option for Lung and Kidney Cancer

    Pegilodecakin, an investigational, first-in-class drug currently in clinical trials, is demonstrating positive safety results and measurable responses when used in combination with pembrolizumab or nivolumab in patients with non-small cell lung cancer (NSCLC) or kidney cancer. The findings from the multicenter, phase IB study were published in Lancet Oncology.

    January 28, 2020
    FDA Approves Tazemetostat for Advanced Epithelioid Sarcoma
    U.S. Food and Drug Administration (FDA)

    FDA Approves Tazemetostat for Advanced Epithelioid Sarcoma

    On January 23, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to tazemetostat for adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.

    January 24, 2020
    HRSA Releases National Survey on RNs
    Health Policy

    HRSA Releases National Survey on RNs

    To better understand the demands and demographics of the larger RN community, the Health Resources Services Agency (HRSA) compiled data from the National Sample Survey of RNs (NSSRN). Released in January 2020, the report is a compendium of information and questions RNs have answered about different aspects of the life and work. The data collected since 1977 provides insight into the latest trends and future workforce projections, and HRSA uses it to help allocate workforce resources.

    January 22, 2020
    NCI Budget Boost; Ending Surprise Medical Billing; Supreme Court ACA Hearing
    Health Policy

    NCI Budget Boost; Ending Surprise Medical Billing; Supreme Court ACA Hearing

    The push and pull of budget negotiations makes for great headlines, but more important is the outcome when lawmakers finally arrive at a consensus. Earlier in December, the National Institutes of Health announced a $2.6 billion overall increase in funding, including a $297 million increase to the National Cancer Institutes (NCI), for fiscal year 2020.

    January 21, 2020
    Breast Cancer Is More Fatal in Men Than Women
    Breast cancer

    Breast Cancer Is More Fatal in Men Than Women

    Men have higher death rates than women across all stages of breast cancer, study findings reported in JAMA Oncology show. In the study, five-year overall survival after a breast cancer diagnosis was 77.6% for men and 86.4% for women.

    January 15, 2020
    What the Research Cautions About Kratom’s Opioid-Like Abuse Potential
    Complementary therapy

    What the Research Cautions About Kratom’s Opioid-Like Abuse Potential

    Kratom is a Southeast Asian tropical tree, the leaves of which have been chewed, smoked, or made as tea for their stimulant and euphoric effects. They have also been employed in traditional medicine to reduce pain and fever, to relieve diarrhea, for wound healing, and as a substitute for opium. Recently, kratom supplements have become popular in the United States for alleviating pain, improving mood, lowering anxiety, and alternative opioid withdrawal treatment.

    January 13, 2020
    Comprehensive Tobacco Treatment Helps Almost Half of Patients Quit Smoking
    Cancer risk prevention

    Comprehensive Tobacco Treatment Helps Almost Half of Patients Quit Smoking

    After nine months of follow-up, 44% of patients in a comprehensive tobacco treatment program were compliant with smoking abstinence, according to the results of a study published in JAMA Network Open.

    January 08, 2020
    Experts Recommend Tailored Exercise for All Cancer Treatment Plans
    Research

    Experts Recommend Tailored Exercise for All Cancer Treatment Plans

    Systemic use of exercise prescriptions not only lowers the risk of certain cancers but also helps to improve side effects and survival from cancer and should therefore be incorporated into cancer treatment plans, experts from the American College of Sports Medicine and 17 partner organizations said in articles published in Medicine and Science in Sports and Exercise and CA: A Cancer Journal for Clinicians.

    December 25, 2019
    Multigene Testing Is Cost Effective for All Women With Breast Cancer
    Genetics & genomics

    Multigene Testing Is Cost Effective for All Women With Breast Cancer

    According to findings from a new analysis published in JAMA Oncology, multigene testing should be expanded to all women with breast cancer and not just those with certain family histories or clinical factors.

    December 20, 2019
    Combining Tamoxifen and Blue Light Can Better Target CAR T Cells
    Research

    Combining Tamoxifen and Blue Light Can Better Target CAR T Cells

    Bioengineers may have found a way to use tamoxifen activated with blue light to control precisely which tissues and body areas CAR T cells attack, reducing toxicities in other parts of the body. They reported their work in ACS Synthetic Biology.

    December 18, 2019
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Next page
    • Last page Last »
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    • Oncology nurse influence
    View All Topics
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2021 Oncology Nursing Society
     
    Back to Top ▲